Cargando…

Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy

With emerging SARS-CoV-2 variants, vaccines approved so far are under scrutiny for long term effectiveness against the circulating strains. There is a prevalent obsession with humoral immunity as in vitro studies have indicated diminished effects of vaccine-induced neutralizing antibodies. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankaranarayanan, S., Mohkhedkar, Mugdha, Janakiraman, Vani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109158/ https://www.ncbi.nlm.nih.gov/pubmed/35568352 http://dx.doi.org/10.1016/j.bbadis.2022.166432

Ejemplares similares

Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement
por: Mohkhedkar, Mugdha, et al.
Publicado: (2021)

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
por: Paul, Debadrita, et al.
Publicado: (2021)

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
por: He, Ping, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
por: Triveri, Alice, et al.
Publicado: (2021)

Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
por: Magazine, Nicholas, et al.
Publicado: (2023)

Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
por: Wang, Zijun, et al.
Publicado: (2022)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Omicron mutations increase interdomain interactions and reduce epitope exposure in the SARS-CoV-2 spike
por: Wieczór, Miłosz, et al.
Publicado: (2023)

Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
por: Wang, Yudong, et al.
Publicado: (2023)

The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
por: Mohammadi, Mehrdad, et al.
Publicado: (2021)

Identification of two antigenic epitopes on SARS-CoV spike protein
por: Hua, Ronghong, et al.
Publicado: (2004)

Computational epitope map of SARS-CoV-2 spike protein
por: Sikora, Mateusz, et al.
Publicado: (2021)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
por: Changrob, Siriruk, et al.
Publicado: (2021)

Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike
por: Wilson, Patrick, et al.
Publicado: (2021)

An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates
por: Ashik, Arafat Islam, et al.
Publicado: (2020)

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2006)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
por: Yang, Chee-Hing, et al.
Publicado: (2021)

Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity
por: Riou, Catherine, et al.
Publicado: (2022)

Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
por: Ismail, Saba, et al.
Publicado: (2020)

Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
por: Finkelstein, Maxwell T., et al.
Publicado: (2021)

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein
por: Kathwate, Gunderao H.
Publicado: (2022)

Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
por: Umitaibatin, Ramadhita, et al.
Publicado: (2023)

Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations
por: Yalcin, Dicle, et al.
Publicado: (2023)

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
por: Forcelloni, Sergio, et al.
Publicado: (2021)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

SARS-CoV-2 Variant Spike and accessory gene mutations alter pathogenesis
por: McGrath, M.E., et al.
Publicado: (2022)

SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis
por: McGrath, Marisa E., et al.
Publicado: (2022)

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
por: Cocherie, Théophile, et al.
Publicado: (2022)

Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
por: Bagherzadeh, Mohammad Aref, et al.
Publicado: (2022)

Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2007)

Epitope mapping of spike identifies variant-resistant antibodies
por: Flemming, Alexandra
Publicado: (2021)

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
por: Kovacech, Branislav, et al.
Publicado: (2022)

The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant
por: Thongkum, Weeraya, et al.
Publicado: (2022)

Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
por: Geanes, Eric S., et al.
Publicado: (2022)

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
por: Seow, Jeffrey, et al.
Publicado: (2022)

Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities
por: Sun, Qi, et al.
Publicado: (2022)

Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates
por: Stuible, Matthew, et al.
Publicado: (2023)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lif6elc8gtrgn3akfe9i9oe9a